Novant Health Cancer Institute Hematology — Charlotte, North Carolina

Novant Health Cancer Institute Hematology is a clinical research site located in Charlotte, North Carolina, United States 28204.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Novant Health Cancer Institute Hematology has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Blastic Plasmacytoid Dendritic Cell Neoplasm, Myeloproliferative Neoplasm.

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Novant Health Cancer Institute Hematology?

Novant Health Cancer Institute Hematology has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Novant Health Cancer Institute Hematology conducted?

Novant Health Cancer Institute Hematology has 1 clinical trials on record, with 1 currently active. Their work covers Blastic Plasmacytoid Dendritic Cell Neoplasm, Myeloproliferative Neoplasm.

Is Novant Health Cancer Institute Hematology accredited by Crixeo Health?

Novant Health Cancer Institute Hematology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Novant Health Cancer Institute Hematology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.